Salirasib
Tocris Bioscience | Catalog # 4989
Key Product Details
Description
Product Description
Salirasib is an inhibitor of active Ras proteins. Displaces active Ras from the plasma membrane; impairs downstream signaling and inhibits proliferation of endometrial carcinoma cells. Also facilitates Ras degradation. Shown to induce autophagy in several human cancer cell lines.
Product Specifications for Salirasib
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 35.85 | 100 | |
| 1eq. NaOH | 17.93 | 50 |
Preparing Stock Solutions for Salirasib
The following data is based on the product molecular weight 358.54.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.79 mL | 13.95 mL | 27.89 mL |
| 5 mM | 0.56 mL | 2.79 mL | 5.58 mL |
| 10 mM | 0.28 mL | 1.39 mL | 2.79 mL |
| 50 mM | 0.06 mL | 0.28 mL | 0.56 mL |
Calculators
Background References
References are publications that support the biological activity of the product.
- Faigenbaum Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib. Oncotarget 2013 PMID: 23530112
- Haklai Dislodgement and accelerated degradation of Ras. Biochemistry 1998 PMID: 9477957
- Schmukler Ras inhibition enhances autophagy, which partially protects cells from death. Oncotarget 2013 PMID: 23370967
Product Documents for Salirasib
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Salirasib
For research use only
Citations for Salirasib
Customer Reviews for Salirasib (1)
Have you used Salirasib?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroCell Line/Tissue: OsteosarcomaVerified Customer | Posted 12/13/2018Human osteosarcoma cells were incubated with 20 μM Salirasib for 30 min prior to treatment with 10 μM LPA to estimate COX-2 expression using Western blot analysis. Salirasib abolished LPA-induced COX-2 expression.
There are no reviews that match your criteria.